Windtree Therapeutics, Inc. (WINT)

NASDAQ: WINT · IEX Real-Time Price · USD

3.130

-0.090 (-2.80%)

At close: Jul 2, 2024, 3:59 PM

2.960

-0.170 (-5.43%)

After-hours: Jul 2, 2024, 6:47 PM EDT

Windtree Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 1995
Net Income	-20.29	-39.21	-67.64	-32.57	-27.48	Upgrade
Depreciation & Amortization	0.49	1.06	0.87	0.64	1.11	Upgrade
Share-Based Compensation	1.28	3.09	7.24	5.68	6.72	Upgrade
Other Operating Activities	5.09	15.61	35.87	0.93	-5.02	Upgrade
Operating Cash Flow	-13.44	-19.45	-23.66	-25.32	-24.66	Upgrade
Capital Expenditures	-0.02	0.2	-0.28	-0.29	-0.19	Upgrade
Change in Investments	0	0	0	0	13.99	Upgrade
Investing Cash Flow	-0.02	0.2	-0.28	-0.29	13.8	Upgrade
Share Issuance / Repurchase	12.39	4.25	32.23	20.39	22.98	Upgrade
Debt Issued / Paid	-0.8	-1.17	-3.87	-3.23	-1.06	Upgrade
Other Financing Activities	-	-	1	2.8	-0.15	Upgrade
Financing Cash Flow	11.6	3.08	29.36	19.96	21.77	Upgrade
Exchange Rate Effect	0	0	0	0	0.47	Upgrade
Net Cash Flow	-1.86	-16.18	5.42	-5.65	11.37	Upgrade
Free Cash Flow	-13.45	-19.26	-23.94	-25.61	-24.85	Upgrade
Free Cash Flow Margin	-	-	-	-	-12552.53%	Upgrade
Free Cash Flow Per Share	-62.47	-550.14	-870.65	-1472.20	-2046.94	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).